Pre-Tax Profit Margin (Quarterly)

Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues

Kura Oncology, Inc. (KURA) had Pre-Tax Profit Margin of -401.45% for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$18.27M
Net Income	$-73.33M
Cost of Goods Sold	$0.26M
Gross Profit	$18.00M
Operating Expenses	$97.08M
Operating Income	$-78.81M
Non-Operating Income/Expense	$5.49M
Pre-Tax Income	$-73.33M
Normalized Pre-Tax Income	$-73.33M
Income after Taxes	$-73.33M
Income from Continuous Operations	$-73.33M
Consolidated Net Income/Loss	$-73.33M
Normalized Income after Taxes	$-73.33M
EBIT	$-78.81M
EBITDA	$-79.36M
Weighted-Average Shares Outstanding (Basic)	88.61M
Weighted-Average Shares Outstanding (Diluted)	88.61M
Earnings per Share (EPS) (Basic)	$-0.83
Earnings per Share (EPS) (Diluted)	$-0.83
Balance Sheet Financials
Current Assets	$623.78M
Property, Plant, and Equipment	$7.61M
Long-Term Assets	$28.77M
Total Assets	$652.55M
Current Liabilities	$101.50M
Long-Term Debt	$9.75M
Long-Term Liabilities	$443.17M
Total Liabilities	$544.67M
Common Equity	$107.88M
Tangible Shareholders Equity	$107.88M
Shareholders Equity	$107.88M
Common Shares Outstanding	88.76M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-85.85M
Cash Flow from Investing Activities	$-24.23M
Cash Flow from Financial Activities	$0.07M
Beginning Cash	$149.10M
End Cash	$39.08M
Increase/Decrease in Cash	$-110.02M
Stock-Based Compensation	$8.42M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	6.15
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.08
Debt to Equity Ratio	0.09
Gross Margin	98.57%
Operating Margin	-431.51%
EBIT Margin	-431.51%
EBITDA Margin	--
Pre-Tax Profit Margin	-401.45%
Profit Margin	-401.49%
Free Cash Flow	$-85.98M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.03
Inventory Turnover	0.31
Receiveable Turnover	1.95
Days Sales in Receivables	46.06
Return on Equity	-67.97%
Return on Tangible Equity	-67.97%
Return on Assets	-11.24%
Return on Investments	-62.34%
Book Value Per Share	$1.22
Free Cash Flow per Share	$-0.97
Operating Cash Flow per Share	$-0.97

Data from Zacks Investment Research, Inc.